Ad Hoc Stem Cell Medical Research? Eight General Principles For Its Advance Stem cell medicine has a new rapidly moving frontier of research and treatment activity. To help keep that frontier from getting too wild, stem cellbiologist and physician scientist James Sherley recently teamed up with Boston Biolife to provide continuing stem cell medical education
Adult tissue stem cells have a growing list of current and potential medical applications, including drug development; gene therapy; bone marrow or corneal restoration; treatments for low back pain and other degenerative joint diseases; treatments for heart attack and stroke; treatment for chronic illnesses like multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS); treatment for
Since the beginnings of the field of stem cell biology, more than half a century ago, it has not been possible to count adult tissue stem cells in experimental and clinical preparations. This surprising, but widely known, situation exists because, although tissue stem cells are unique in function from all other tissue cells, they do
With Disclosure of Recently Met Benchmarks for Its Adult Tissue Stem Cell Counting Technology, Asymmetrex Targets Applications to Enable Gene-Editing Therapies Yesterday, tissue stem cell biotechnology start-up company Asymmetrex, LLC posted results on its website from the most recently completed benchmark studies for its computer simulation technology for determining the number of stem cells in
Stem Cell Therapy for Pets June 18, 2015 Asymmetrex calls for the scientific method to understand pet “stem cell” therapies. “Once, some farmers thought that shed horsehairs spontaneously generated living worms, until the scientific method uncovered associated Gordian worms as the responsible organisms. In contrast, when extracts of foxglove plants were found to help dropsy
Asymmetrex Launches a Crowdsourcing Campaign to Introduce New Biomarkers for Counting Previously Elusive Tissue Stem Cells To go directly to the Asymmetrex crowd description page, click here. Stem cell medicine technology start-up company Asymmetrex, LLC faces the unusual challenge of wishing to evaluate its new biomarker technologies, developed to count tissue stem cells for the
Asymmetrex Scheduled to Present Unique Perspectives in Stem Cell Biology and Recent Advances in Technologies for Adult Stem Cell Medicine at U.S. and U.K. Conferences Already in 2015, the adult stem cell technology company Asymmetrex is scheduled to present at both industry and academic conferences in the U.S. and the U.K. The company will share
Sparse feature selection identifies H2A.Z as a novel, pattern-specific biomarker for asymmetrically self-renewing distributed stem cells Yang Hoon Huh, Minsoo Noh, Frank R. Burden, Jennifer C. Chen, David A. Winkler, James L. Sherley Abstract There is a long-standing unmet clinical need for biomarkers with high specificity for distributed stem cells (DSCs) in tissues, or for use in diagnostic and therapeutic
For Immediate Release Boston, MA (PRWEB) December 23, 2014 Adult Stem Cell Technology Center, LLC’s Director Sherley’s Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website This month a keynote address by Dr. James L. Sherley, Director of Boston’s Adult Stem Cell Technology Center, LLC, is featured on the website of the
For immediate release. Boston, Massachusetts (PRWEB) September 25, 2014 The Adult Stem Cell Technology Center, LLC Presents Its New Company Initiatives At The 2014 BioPharm America International Partnering Conference in Boston, MA A year after its formation in September 2013, Boston’s Adult Stem Cell Technology Center, LLC (ASCTC) was invited to present its commercialization plans and